Download PDF
1 / Pages

Other users also viewed these articles

IgG4-related disease: Is rituximab the best therapeutic strategy for cases refractory to conventional therapy? Results of a systematic review Laura Betancur-Vásquez; Daniel Gonzalez-Hurtado; Daniela Arango-Isaza; Adriana Rojas-Villarraga; Deicy Hernandez-Parra; Samuel Carmona; J.C. Díaz-Coronado;
Reumatol Clin. 2020;16:195-202
Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report Paira Sergio; Reibaldi Alejandro; Froullet Cristian;
Reumatol Clin. 2023;19:338-44
Aphthous stomatitis and laryngitis, another form of presentation of an IgG4-related disease? Silvia Suárez-Díaz; Faustino Núñez-Batalla; María Soledad Fernández-García; María Belén Fernández-Llana; Carmen Yllera-Gutiérrez; Luis Caminal-Montero;
Reumatol Clin. 2020;16P2:416-8